Clorox (CLX) to Release Earnings on Tuesday

Clorox (NYSE:CLX) is expected to be announcing its Q2 2026 results after the market closes on Tuesday, February 3rd. Analysts expect the company to announce earnings of $1.46 per share and revenue of $1.6406 billion for the quarter. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 5:00 PM ET.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the prior year, the firm posted $1.86 EPS. The company’s revenue was down 18.9% compared to the same quarter last year. On average, analysts expect Clorox to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Clorox Stock Performance

NYSE CLX opened at $112.84 on Tuesday. The business has a 50 day moving average price of $104.03 and a 200 day moving average price of $114.60. The company has a market capitalization of $13.76 billion, a P/E ratio of 17.71, a PEG ratio of 0.57 and a beta of 0.58. Clorox has a 1-year low of $96.66 and a 1-year high of $164.22. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is 77.86%.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. The trade was a 44.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

Several hedge funds have recently made changes to their positions in CLX. IHT Wealth Management LLC grew its stake in shares of Clorox by 25.2% during the 2nd quarter. IHT Wealth Management LLC now owns 5,835 shares of the company’s stock valued at $701,000 after buying an additional 1,173 shares during the period. Great Valley Advisor Group Inc. boosted its holdings in Clorox by 23.6% in the second quarter. Great Valley Advisor Group Inc. now owns 5,445 shares of the company’s stock valued at $653,000 after acquiring an additional 1,041 shares during the last quarter. CTC Alternative Strategies Ltd. purchased a new stake in Clorox during the second quarter valued at about $845,000. Quadrant Capital Group LLC increased its stake in Clorox by 14.2% during the third quarter. Quadrant Capital Group LLC now owns 2,159 shares of the company’s stock worth $266,000 after acquiring an additional 268 shares during the last quarter. Finally, Centaurus Financial Inc. raised its holdings in shares of Clorox by 8.5% in the 3rd quarter. Centaurus Financial Inc. now owns 1,906 shares of the company’s stock worth $235,000 after purchasing an additional 150 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research reports. Bank of America lowered their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. The Goldman Sachs Group lowered their price target on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research report on Wednesday, January 7th. Wall Street Zen downgraded Clorox from a “hold” rating to a “sell” rating in a research report on Saturday. Wells Fargo & Company upped their target price on Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, UBS Group lowered their target price on Clorox from $119.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, January 14th. One research analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $122.19.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.